AbbVie Inc (NYSE:ABBV)

91.53
Delayed Data
As of Nov 16
 +1.39 / +1.54%
Today’s Change
77.50
Today|||52-Week Range
125.86
-5.36%
Year-to-Date

Today’s Trading

Previous close90.14
Today’s open89.73
Day’s range89.20 - 92.00
Volume8,691,056
Average volume (3 months)6,299,078
Market cap$137.7B
Data as of 4:04pm ET, 11/16/2018

Growth & Valuation

Earnings growth (last year)-9.32%
Earnings growth (this year)+42.01%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+10.06%
P/E ratio19.0
Price/Sales5.49
Price/Book28.59

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+1.31+1.85%
LLYEli Lilly and Co+1.63+1.45%
SNYSanofi+0.53+1.19%
AZNAstraZeneca-0.73-1.76%
Data as of 4:02pm ET, 11/16/2018

Financials

Next reporting dateJanuary 25, 2019
EPS forecast (this quarter)$1.94
Annual revenue (last year)$28.2B
Annual profit (last year)$5.3B
Net profit margin18.72%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts